Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2)

FASEB Journal

Volumn 30, Issue 6, 2016, Pages 2311-2323

  Noy, Peter J ^a   Swain, Rajeeb K ^a,b   Khan, Kabir ^a   Lodhia, Puja ^a   Bicknell, Roy ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Institute of Life Science   (India)

Author keywords

Antiangiogenic therapy; Mmrn2; Multimerin 2; Rhomboid substrates

Indexed keywords

C TYPE LECTIN FAMILY 14 MEMBER A; LECTIN; PROTEIN; RHOMBOID LIKE 2 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; CLEC14A PROTEIN, HUMAN; CLEC14A PROTEIN, MOUSE; MEMBRANE PROTEIN; PROTEIN BINDING; PROTEINASE; RHBDL2 PROTEIN, HUMAN; RHBDL2 PROTEIN, MOUSE; SERINE PROTEINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL LYSATE; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE SILENCING; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SITE DIRECTED MUTAGENESIS; SPROUTING ANGIOGENESIS; WESTERN BLOTTING; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; BIOMECHANICS; C57BL MOUSE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; ANIMALS; BIOMECHANICAL PHENOMENA; CELL ADHESION MOLECULES; CELL MOVEMENT; ENDOPEPTIDASES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; LECTINS, C-TYPE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; PROTEIN DOMAINS; SERINE PROTEASES;

EID: 84973161115     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201500122R     Document Type: Article

References (43)

1. Chung, A. S., and Ferrara, N. (2011) Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Biol. 27, 563-584
2. Potente, M., Gerhardt, H., and Carmeliet, P. (2011) Basic and therapeutic aspects of angiogenesis. Cell 146, 873-887
3. Mura, M., Swain, R. K., Zhuang, X., Vorschmitt, H., Reynolds, G., Durant, S., Beesley, J. F. J., Herbert, J. M. J., Sheldon, H., Andre, M., Sanderson, S., Glen, K., Luu, N.-T., McGettrick, H. M., Antczak, P., Falciani, F., Nash, G. B., Nagy, Z. S., and Bicknell, R. (2012) Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. Oncogene 31, 293-305
4. Ki, M. K., Jeoung, M. H., Choi, J. R., Rho, S.-S., Kwon, Y.-G., Shim, H., Chung, J., Hong, H. J., Song, B. D., and Lee, S. (2013) Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro. Oncogene 32, 5449-5457
5. Rho, S.-S., Choi, H.-J., Min, J.-K., Lee, H.-W., Park, H., Park, H., Kim, Y.-M., and Kwon, Y.-G. (2011) Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion. Biochem. Biophys. Res. Commun. 404, 103-108
6. Zanivan, S., Maione, F., Hein, M. Y., Hernández-Fernaud, J. R., Ostasiewicz, P., Giraudo, E., and Mann, M. (2013) SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers. Mol. Cell. Proteomics 12, 3599-3611
7. Noy, P. J., Lodhia, P., Khan, K., Zhuang, X., Ward, D. G., Verissimo, A. R., Bacon, A., and Bicknell, R. (2015) Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth. Oncogene 34, 5821-5831
8. Zelensky, A. N., and Gready, J. E. (2005) The C-type lectin-like domain superfamily. FEBS J. 272, 6179-6217
9. Greenlee, M. C., Sullivan, S. A., and Bohlson, S. S. (2009) Detection and characterization of soluble CD93 released during inflammation. Inflamm. Res. 58, 909-919
10. Mälarstig, A., Silveira, A., Wågsäter, D., Öhrvik, J., Bäcklund, A., Samnegård, A., Khademi, M., Hellenius, M.-L., Leander, K., Olsson, T., Uhlén, M., de Faire, U., Eriksson, P., and Hamsten, A. (2011) Plasma CD93 concentration is a potential novel biomarker for coronary artery disease. J. Intern. Med. 270,229-236
11. Refaat, L. A., Ali, O. E., Hassan, A. A., and Metwally, A. M. (2012) Urinary thrombomodulin is down regulated in schistosomiasis associated bladder cancer. J. Genet. Eng. Biotech. 10,67-71
12. Lindahl, A. K., Boffa, M. C., and Abildgaard, U. (1993) Increased plasma thrombomodulin in cancer patients. Thromb. Haemost. 69, 112-114
13. Shi, C.-S., Shi, G.-Y., Chang, Y.-S., Han, H.-S., Kuo, C.-H., Liu, C., Huang, H.-C., Chang, Y.-J., Chen, P.-S., and Wu, H.-L. (2005) Evidence of human thrombomodulin domain as a novel angiogenic factor. Circulation 111, 1627-1636
14. Kuo, C.-H., Chen, P.-K., Chang, B.-I., Sung, M.-C., Shi, C.-S., Lee, J.-S., Chang, C.-F., Shi, G.-Y., and Wu, H.-L. (2012) The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen. Blood 119, 1302-1313
15. Kao, Y.-C., Jiang, S.-J., Pan, W.-A., Wang, K.-C., Chen, P.-K., Wei, H.-J., Chen, W.-S., Chang, B.-I., Shi, G.-Y., and Wu, H.-L. (2012) The epidermal growth factor-like domain of CD93 is a potent angiogenic factor. PLoS One 7, e51647
16. Jeon, J. W., Jung, J. G., Shin, E. C., Choi, H. I., Kim, H. Y., Cho, M. L., Kim, S. W., Jang, Y. S., Sohn, M. H., Moon, J. H., Cho, Y. H., Hoe, K. L., Seo, Y. S., and Park, Y. W. (2010) Soluble CD93 induces differentiation of monocytes and enhances TLR responses. J. Immunol. 185, 4921-4927
17. Freeman, M. (2008) Rhomboid proteases and their biological functions. Annu. Rev. Genet. 42, 191-210
18. Higashiyama, S., Iwabuki, H., Morimoto, C., Hieda, M., Inoue, H., and Matsushita, N. (2008) Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci. 99, 214-220
19. Adrain, C., Strisovsky, K., Zettl, M., Hu, L., Lemberg, M. K., and Freeman, M. (2011) Mammalian EGF receptor activation by the rhomboid protease RHBDL2. EMBO Rep. 12, 421-427
20. Seals, D. F., and Courtneidge, S. A. (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17,7-30
21. Lohi, O., Urban, S., and Freeman, M. (2004) Diverse substrate recognition mechanisms for rhomboids; thrombomodulin is cleaved by mammalian rhomboids. Curr. Biol. 14, 236-241
22. Hansson, M. D., Rzeznicka, K., Rosenbäck, M., Hansson, M., and Sirijovski, N. (2008) PCR-mediated deletion of plasmid DNA. Anal. Biochem. 375,373-375
23. Urban, S., Lee, J. R., and Freeman, M. (2002) A family of rhomboid intramembrane proteases activates all Drosophila membrane-tethered EGF ligands. EMBO J. 21, 4277-4286
24. Maciag, T., Cerundolo, J., Ilsley, S., Kelley, P. R., and Forand, R. (1979) An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc. Natl. Acad. Sci. USA 76, 5674-5678
25. Desjobert, C., Noy, P., Swingler, T., Williams, H., Gaston, K., and Jayaraman, P.-S. (2009) The PRH/Hex repressor protein causes nuclear retention of Groucho/TLE co-repressors. Biochem. J. 417, 121-132
26. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
27. Lemberg, M. K., Menendez, J., Misik, A., Garcia, M., Koth, C. M., and Freeman, M. (2005) Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases. EMBO J. 24, 464-472
28. Strisovsky, K., Sharpe, H. J., and Freeman, M. (2009) Sequence-specific intramembrane proteolysis: identification of a recognition motif in rhomboid substrates. Mol. Cell 36, 1048-1059
29. Bergbold, N., and Lemberg, M. K. (2013) Emerging role of rhomboid family proteins in mammalian biology and disease. Biochim. Biophys. Acta 1828, 2840-2848
30. Cheng, T.-L., Wu, Y.-T., Lin, H.-Y., Hsu, F.-C., Liu, S.-K., Chang, B.-I., Chen, W.-S., Lai, C.-H., Shi, G.-Y., and Wu, H.-L. (2011) Functions of rhomboid family protease RHBDL2 and thrombomodulin in wound healing. J. Invest. Dermatol. 131, 2486-2494
31. Pascall, J. C., and Brown, K. D. (2004) Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. Biochem. Biophys. Res. Commun. 317,244-252
32. Rettig, W. J., Garin-Chesa, P., Healey, J. H., Su, S. L., Jaffe, E. A., and Old, L. J. (1992) Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc. Natl. Acad. Sci. USA 89, 10832-10836
33. Conway, E. M. (2012) Thrombomodulin and its role in inflammation. Semin. Immunopathol. 34, 107-125
34. MacFadyen, J. R., Haworth, O., Roberston, D., Hardie, D., Webster, M.-T., Morris, H. R., Panico, M., Sutton-Smith, M., Dell, A., van der Geer, P., Wienke, D., Buckley, C. D., and Isacke, C. M. (2005) Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett. 579, 2569-2575
35. Moin, S. M., and Urban, S. (2012) Membrane immersion allows rhomboid proteases to achieve specificity by reading transmembrane segment dynamics. eLife 1, e00173
36. Urban, S., and Moin, S. M. (2014) A subset of membrane-altering agents and γ-secretase modulators provoke nonsubstrate cleavage by rhomboid proteases. Cell Rep. 8, 1241-1247
37. Suchting, S., Heal, P., Tahtis, K., Stewart, L. M., and Bicknell, R. (2005) Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration. FASEB J. 19, 121-123
38. Akhtar, N., Dickerson, E. B., and Auerbach, R. (2002) The sponge/Matrigel angiogenesis assay. Angiogenesis 5, 75-80
39. Chen, Y., Wang, S., Lu, X., Zhang, H., Fu, Y., and Luo, Y. (2011) Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. Blood 117, 6392-6403
40. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844
41. Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Lin, H. C., Yancopoulos, G. D., and Thurston, G. (2006) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444, 1032-1037
42. Lorenzon, E., Colladel, R., Andreuzzi, E., Marastoni, S., Todaro, F., Schiappacassi, M., Ligresti, G., Colombatti, A., and Mongiat, M. (2012) MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway. Oncogene 31, 3136-3147
43. Masiero, M., Simões, F. C., Han, H. D., Snell, C., Peterkin, T., Bridges, E., Mangala, L. S., Wu, S. Y.-Y., Pradeep, S., Li, D., Han, C., Dalton, H., Lopez-Berestein, G., Tuynman, J. B., Mortensen, N., Li, J.-L., Patient, R., Sood, A. K., Banham, A. H., Harris, A. L., and Buffa, F. M. (2013) A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis. Cancer Cell 24, 229-241